Doximity upgraded at Raymond James on improving long-term growth visibility
Source: SeekingAlpha
2025-11-21 11:15:38 ET
More on Doximity
- Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript
- Doximity: Valuation Is Too Expensive For My Liking
- Doximity falls despite Q2 beat amid uncertainty over client budgets
- Doximity outlines 13% full-year revenue growth target as AI suite accelerates client adoption
- Seeking Alpha’s Quant Rating on Doximity
Read the full article on Seeking Alpha
For further details see:
Doximity upgraded at Raymond James on improving long-term growth visibility
Doximity Inc. Class A
NASDAQ: DOCS
DOCS Trading
-2.4% G/L:
$24.39 Last:
746,042 Volume:
$24.96 Open:
DOCS Latest News
February 23, 2026 01:35:00 am
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.
DOCS Stock Data
$5,029,624,926
180,645,361
N/A
184
N/A
Healthcare Providers & Services
Healthcare
US
San Francisco
